Selkirk Pharma raises $24M in seed funding
Selkirk Pharma, a Spokane-based startup, raised $24.1 million to support its development of sterile therapeutics. The funding, which came from unnamed investors, brings Selkirk’s total valuation above $375 million.
The pharmaceutical company, which was founded in 2018, plans to build a three-plant manufacturing campus on the city’s West Plains. One facility has already been built and houses over 100,000 square feet.
According to Selkirk, the manufacturing facilities “will incorporate industry-leading technology, including isolator-based filling systems and electronic batch records.”